Showing results (1831-1840 of 1,873) with videos related to

Sort By:
Pageof 188
Plos One|February 29, 2024
Climate change increases threat to plant diversity in tropical forests of Central America and southern MexicoMiguel A Ortega, Luis Cayuela, Daniel M Griffith, et al.
Transplantation and Cellular Therapy|July 4, 2025
Assessing cognitive function in transplantation and chimeric antigen receptor t cell therapy recipients: Expert recommendations from the survivorship, aging and biobehavioral special interest groups of the American Society for Transplantation and Cellular TherapyVanessa E Kennedy, Nausheen Ahmed, Andy Artz, et al.
Science (New York, N.Y.)|May 11, 2023
Constraints on the Hubble constant from supernova Refsdal's reappearancePatrick L Kelly, Steven Rodney, Tommaso Treu, et al.
Nature|May 17, 2023
Inhibiting membrane rupture with NINJ1 antibodies limits tissue injuryNobuhiko Kayagaki, Irma B Stowe, Kamela Alegre, et al.
Critical Care Medicine|October 20, 2018
Caring for Critically Ill Patients with the ABCDEF Bundle: Results of the ICU Liberation Collaborative in Over 15,000 AdultsBrenda T Pun, Michele C Balas, Mary Ann Barnes-Daly, et al.
Nature Communications|November 28, 2018
VDAC2 enables BAX to mediate apoptosis and limit tumor developmentHui San Chin, Mark X Li, Iris K L Tan, et al.
Journal of the International AIDS Society|April 14, 2018
How should HIV resources be allocated? Lessons learnt from applying Optima HIV in 23 countriesRobyn M Stuart, Laura Grobicki, Hassan Haghparast-Bidgoli, et al.
Science (New York, N.Y.)|March 7, 2015
Astrophysics. Multiple images of a highly magnified supernova formed by an early-type cluster galaxy lensPatrick L Kelly, Steven A Rodney, Tommaso Treu, et al.
Schizophrenia Research|August 26, 2023
Clozapine and neutrophil response in patients of African descent: A six-month, multinational, prospective, open-label clinical trialDeanna L Kelly, Matthew Glassman, Ikwunga Wonodi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 14, 2018
FDA Approval Summary: Niraparib for the Maintenance Treatment of Patients with Recurrent Ovarian Cancer in Response to Platinum-Based ChemotherapyGwynn Ison, Lynn J Howie, Laleh Amiri-Kordestani, et al.
Pageof 188